Basivertebral Nerve Ablation With the Intracept Procedure
Unknown statusPhase 4NCT05692440
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is an independent prospective, noninterventional, single arm post market data collection of the patient-reported effectiveness, ongoing safety, and satisfaction outcomes for patients treated with intraosseous basivertebral nerve ablation using the Intracept Procedure at a single study site.
Study details
- Official title
- Prospective, Single-Arm, Cohort Study on Basivertebral Nerve Ablation With the Intracept Procedure
- Conditions
- Interventions
- Device: Intracept Procedure
- Sponsor
- Neuro Spine and Pain Center of Key West
- Start date
- 2021-05-03
- Primary completion
- 2026-01-01
- Sex
- All
- Age range
- from 18 Years to 84 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult patients ≥18 years of age * Patients who have experienced chronic low back pain for ≥6 months. * Patients who have not responded to at least 6 months of conservative care. * Patients with Modic type 1 or 2 changes. Exclusion Criteria: * Patients with severe cardiac or pulmonary disease. * Patients with active systemic infection or localized infection in the treatment area.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05692440